TRAMONTANO, ENZO
 Distribuzione geografica
Continente #
EU - Europa 421.321
NA - Nord America 22.245
AS - Asia 9.434
SA - Sud America 1.488
Continente sconosciuto - Info sul continente non disponibili 1.034
AF - Africa 310
OC - Oceania 26
Totale 455.858
Nazione #
IT - Italia 416.308
US - Stati Uniti d'America 21.756
SG - Singapore 3.626
CN - Cina 3.074
SE - Svezia 1.216
BR - Brasile 1.119
UA - Ucraina 973
VN - Vietnam 894
DE - Germania 630
FI - Finlandia 571
GB - Regno Unito 504
FR - Francia 442
HK - Hong Kong 347
BD - Bangladesh 258
CA - Canada 240
IN - India 240
KR - Corea 172
AR - Argentina 142
NL - Olanda 131
MX - Messico 106
TR - Turchia 105
JP - Giappone 98
IQ - Iraq 95
MA - Marocco 93
RU - Federazione Russa 87
AT - Austria 81
PL - Polonia 77
ZA - Sudafrica 72
PK - Pakistan 68
EC - Ecuador 65
ES - Italia 61
ID - Indonesia 58
CO - Colombia 41
SA - Arabia Saudita 39
IL - Israele 38
IR - Iran 38
BE - Belgio 36
VE - Venezuela 34
PH - Filippine 33
UZ - Uzbekistan 32
IE - Irlanda 29
JM - Giamaica 29
AE - Emirati Arabi Uniti 25
CL - Cile 25
TN - Tunisia 25
CZ - Repubblica Ceca 22
AU - Australia 21
KE - Kenya 21
AZ - Azerbaigian 19
EG - Egitto 19
JO - Giordania 19
PY - Paraguay 19
CR - Costa Rica 18
NP - Nepal 18
TW - Taiwan 18
LT - Lituania 17
MY - Malesia 17
NI - Nicaragua 17
PT - Portogallo 17
BO - Bolivia 14
DZ - Algeria 14
ET - Etiopia 14
DK - Danimarca 13
UY - Uruguay 13
GE - Georgia 12
GT - Guatemala 12
PE - Perù 12
PR - Porto Rico 12
EU - Europa 11
GR - Grecia 11
HN - Honduras 11
KG - Kirghizistan 11
OM - Oman 11
CH - Svizzera 10
TH - Thailandia 10
LB - Libano 9
LV - Lettonia 9
NO - Norvegia 9
RO - Romania 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
AL - Albania 8
KZ - Kazakistan 8
QA - Qatar 8
SC - Seychelles 8
CW - ???statistics.table.value.countryCode.CW??? 7
EE - Estonia 7
HU - Ungheria 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 6
GP - Guadalupe 6
HR - Croazia 6
MU - Mauritius 6
NG - Nigeria 6
AM - Armenia 5
DO - Repubblica Dominicana 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
CI - Costa d'Avorio 4
Totale 454.761
Città #
Cagliari 404.504
Uta 9.931
Ashburn 2.694
Singapore 1.980
Fairfield 1.590
San Jose 1.465
Woodbridge 1.322
Dallas 1.040
Chandler 993
Boardman 918
Houston 836
Nyköping 727
Seattle 668
Wilmington 648
Beijing 583
Ann Arbor 561
Cambridge 551
Council Bluffs 546
Los Angeles 485
Jacksonville 475
New York 431
Helsinki 373
Santa Clara 362
Dearborn 350
Hong Kong 293
Lauterbourg 245
Ho Chi Minh City 236
Shanghai 235
Hefei 222
The Dalles 215
Boston 201
Nanjing 186
Hanoi 175
Rome 173
Dong Ket 170
Buffalo 155
Seoul 151
Milan 138
Chicago 124
San Diego 110
São Paulo 107
Columbus 106
Phoenix 94
Munich 91
Redwood City 88
Guangzhou 79
Tokyo 77
Toronto 74
Herndon 72
London 71
Atlanta 69
Nanchang 68
Orem 65
Redondo Beach 63
Changsha 60
Warsaw 59
Casablanca 57
Tianjin 57
Frankfurt am Main 55
Amsterdam 54
Vienna 54
Mountain View 53
Shenyang 53
Brooklyn 51
Hangzhou 49
Denver 47
Washington 46
Montreal 44
Jiaxing 43
Rio de Janeiro 42
San Francisco 42
Sassari 42
Verona 42
Mexico City 41
Nuremberg 40
Hebei 38
Lappeenranta 38
Naples 38
Da Nang 35
Baghdad 34
Wuhan 34
Redmond 33
Chennai 32
Istanbul 32
Stockholm 32
Mumbai 31
North Bergen 31
Norwalk 31
Salt Lake City 31
Guayaquil 28
Manchester 28
Tashkent 28
Birmingham 27
Brasília 27
Jinan 26
Brussels 24
Curitiba 24
Haiphong 24
Philadelphia 24
Zhengzhou 24
Totale 439.971
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.860
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.756
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.709
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.561
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.509
Biological activities of aerial parts extracts of Euphorbia characias 4.460
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.357
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.209
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.775
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.533
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.519
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.480
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.469
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.460
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.451
Broad-range potential of Asphodelus microcarpus leaves extract for drug development 3.387
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.384
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.339
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.338
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.324
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.298
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.142
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.124
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.101
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.085
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.066
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.065
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 3.031
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.015
Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans 2.990
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.973
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.961
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.949
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.943
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.907
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.894
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.891
The S-layer protein DR_2577 binds deinoxanthin and under desiccation conditions protects against UV-radiation in Deinococcus radiodurans 2.885
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.882
On the S-layer of Thermus thermophilus and the assembling of its main protein SIpA 2.871
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.837
Insights into Ebola VP35 oligomerization from molecular simulations 2.836
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.805
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.800
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity 2.788
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.747
ANALYSIS OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IDENTIFIED IN THE HUMAN GENOME ASSEMBLY GRCH37/HG19 BY RETROTECTOR AND THEIR GENOMIC CONTEXT 2.738
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.725
null 2.719
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.710
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.658
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.641
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.636
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.624
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.590
Classification and characterization of human endogenous retroviruses; mosaic forms are common 2.583
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.566
Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes 2.505
Human Endogenous Retrovirus type W distribution in the human genome: identification and characterization of a new set of proviral sequences in GRCh37/hg19 assembly 2.492
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.487
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.484
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships 2.459
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.450
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.449
Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds 2.433
Validation of a computed radiography device to monitor the HIV-1 RNase H activity 2.419
An efficient route to novel uracil-based drug-like molecules 2.386
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.384
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.366
Identification and genomic characterization of HERV-K (HML-10) in human genome GRCh37/hg19 assembly 2.345
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.336
null 2.329
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.295
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.284
HERV-W group evolutionary history in non-human primates: Characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini 2.276
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.239
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 2.231
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments 2.228
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.187
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.171
Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses 2.156
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.152
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.132
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.130
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.125
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.112
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.105
New features of the cell wall of the radio-resistant bacterium Deinococcus radiodurans 2.091
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.087
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.074
HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity 2.068
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach 2.058
Ebola virus VP35 blocks stress granule assembly 2.054
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology 2.044
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.017
Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome 1.991
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.947
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.920
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.904
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.899
Totale 305.257
Categoria #
all - tutte 576.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 576.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218.013 0 0 0 1.419 1.852 1.786 1.324 1.202 2.274 2.345 2.865 2.946
2022/202340.300 3.440 5.633 4.589 3.519 2.514 4.377 1.973 3.178 2.117 2.391 3.242 3.327
2023/202438.637 2.373 1.373 2.010 3.476 3.722 6.385 5.038 3.012 1.887 2.286 3.411 3.664
2024/202591.439 15.305 41.501 10.614 7.743 3.619 4.266 5.061 362 795 596 716 861
2025/202621.300 1.402 681 2.392 1.934 1.762 1.440 3.572 1.903 1.418 2.387 1.453 956
2026/20275.766 758 1.050 1.680 2.278 0 0 0 0 0 0 0 0
Totale 455.858